We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Aminosalicylic Acid Treats Manganese Intoxication

By Biotechdaily staff writers
Posted on 07 Jul 2006
A recent study described the 17-year follow-up of a patient suffering from chronic manganese (Mn) intoxication, a syndrome resembling Parkinson's disease, who was successfully treated with aminosalicylic acid.

Aminosalicylic acid (also known as p-aminosalicylic acid or 5-aminosalicylic acid) is an antibiotic used to treat tuberculosis. More...
In addition, it has been used for over forty years in the treatment of inflammatory bowel diseases, where it has shown greater potency in Crohn's Disease. It is thought to act via NF-kB (Nuclear Factor kappa B) inhibition and free radical scavenging.

Investigators at Purdue University (West Lafayette, IN, USA) evaluated a 67-year old female patient who had been treated for Mn intoxication 17 years previously after having been exposed to airborne Mn for 21 years (1963-1984). At the time of treatment the patient had palpitations, hand tremor, lower limb myalgia, hypermyotonia, and a distinct festinating gait.

The patient was treated with six grams of aminosalicylic acid per day through an intravenous drip infusion for four days and rested for three days as one therapeutic course. Fifteen such courses were carried out between March and June 1987. At the end of the treatment, her symptoms were significantly alleviated, and handwriting recovered to normal.

The current paper, published in the June 2006 issue of the Journal of Occupational Environmental Medicine, reported that in 2004 the patient demonstrated a general normal presentation in clinical, neurologic, brain magnetic resonance imaging, and handwriting examinations with a minor yet passable gait.

Senior author Dr. Wei Zheng, professor of public health at Purdue University, said, "When manganese builds up in toxic levels in the body, people suffer from ‘occupational manganese parkinsonism,' which causes symptoms similar to Parkinson's disease. Victims experience hand tremors, poor coordination, unsteady gait, and a mask-like inability to show facial expressions. The amazing thing is that this drug reverses Parkinson-type symptoms of manganese intoxication. We see remarkable improvement after treatment with this drug even 17 years later.”



Related Links:
Purdue University

New
Gold Member
Aspiration System
VACUSAFE
Gold Member
Quality Control Material
iPLEX Pro Exome QC Panel
New
Electrolyte Analyzer
CBS-4000 (CBS-400)
New
Automated Urinalysis Solution
UN-9000
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image

Urine-Based Multi-Cancer Screening Test Receives FDA Breakthrough Device Designation

Early detection across multiple cancers remains a major unmet need in population screening. Non-invasive approaches that can be delivered at scale may broaden access and shift diagnoses to earlier stages.... Read more

Molecular Diagnostics

view channel
Image: The new approach focuses on CpG DNA methylation, a chemical modification of cytosine and guanine bases, using tumor samples to develop a computational model that distinguishes among 21 cancer types (photo credet: 123RF)

Machine Learning Model Uses DNA Methylation to Predict Tumor Origin in Cancers of Unknown Primary

Cancers of unknown primary (CUP) are metastatic malignancies in which the primary site cannot be identified, complicating treatment selection. Many patients consequently receive broad, nonspecific chemotherapy... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.